Lifespan extension in animal studies Rodent studies (most extensive data): Mice lifespan increased 20-42% with Epithalon Rats showed 12-25% lifespan extension Both maximum lifespan and median lifespan increased Healthspan (healthy years) improved even more Similar to effects seen with caloric restriction but without dietary limitation Study examples: Mechanisms of lifespan extension: Telomere preservation preventing cellular senescence Reduced oxidative damage to tissues Improved immune function preventing infections Better hormone regulation (pineal, reproductive) Reduced age-related diseases (cancer, cardiovascular) Human lifespan effects (theoretical): No completed human lifespan studies (require decades) If similar extension: 20% of 80-year lifespan = 16 additional years More realistically: Healthspan improvement more achievable than lifespan Quality of life in later years potentially enhanced Similar goals as other longevity interventions Limitations of animal data: Rodents humans (metabolism, telomere biology differ) Controlled lab conditions vs real-world human life Optimal dosing in humans unknown Long-term safety in humans not established Need rigorous human trials for validation Compare to other longevity approaches like growth hormone peptides at SeekPeptides

This framework is intended to help you structure a productive conversation with your functional medicine provider
Impact of DIPNECH on Outcomes of Pulmonary Carcinoid Tumor Resection: Single Institution Experience
Understanding Solution Behavior For deeper insight into how L-carnitine behaves in solution: Why L-carnitine solutions turn yellow Shelf life of L-carnitine in aqueous solutions Oral vs injectable L-carnitine Product Details Format: Single vial Sterility: Sterile Storage: 28C for long-term storage Short-term: Stable under controlled room conditions Terms of Use This material is sold for laboratory research purposes only.Not for human consumption or use in medical, veterinary, or household applications
Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases
3-HFAs can activate G protein-coupled receptors and thereby regulate the pleiotropic effects of metformin (Naja et al., 2024)